Aeterna Zentaris Inc (NASDAQ:AEZS)

0.218
BATS BZX Real-Time Price
As of 9:56am ET
 +0.0167 / +8.30%
Today’s Change
0.16
Today|||52-Week Range
0.98
-38.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$25.0M

Company Description

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company, which engages in the development of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.

Contact Information

Æterna Zentaris, Inc.
222 Bay Street
Toronto Ontario M5K 1E7
P:(418) 652-8525
Investor Relations:

Employees

Shareholders

Other institutional0.91%
Mutual fund holders0.08%
Individual stakeholders--

Top Executives

Klaus Wolfgang PauliniPresident, Chief Executive Officer & Director
Giuliano La FrattaChief Financial Officer & Senior Vice President
Michael TeifelChief Scientific Officer & Senior Vice President
Nicola AmmerChief Medical Officer & Senior Vice President
Matthias GerlachVice President-Manufacturing & Supply Chain